As the recipient mice of Tet2;StingDKO BM donor cells exhibited normal hematopoietic hierarchy and significantly extended survival, we wondered whether STING inhibition is able to restrain the skewed differentiation and leukemia progression of TET2-mutated human blood cells in vitro and in engrafted mice. This evidence concerns the gene TET2 and leukemia.